- Targeted Pathways in Prostate Cancers
- Radioligand Therapies for Metastatic CRPC
- Insights from ASCO GU 2025: Developments in Muscle-Invasive Bladder Cancer (MIBC)
- Navigating Combination Regimens for Advanced Clear-Cell RCC
- Emerging Treatments in Non-Clear Cell RCC
- Clinical Scenarios: Clear Cell/Non-Clear Cell RCC
OncLive® State of the Science Summit™: Genitourinary Cancers
The Study at University City
20 S 33rd St
Philadelphia, PA 19104
May 6, 2025
6:00 PM-9:00 PM ET
Complimentary Parking
In-Person Only
Event Chair
Vivek K. Narayan, MD, MS
Penn Medicine Abramson Cancer Center
IN PARTNERSHIP WITH
OVERVIEW
OncLive® State of the Science Summit™ (SOSS) are in-person meetings designed for academic & community-based physicians and health care professionals that provide education on the science driving updates in cancer management and the associated clinical benefits for patients. SOSS attendees will improve their knowledge of novel treatment approaches and reinforce their confidence in applying state-of-the-art treatment strategies.
Registration for this Summit is complimentary.
TOPICS INCLUDE:
Location
The Study at University City 20 S 33rd St, Philadelphia, PA, USA
OncLive - an MJH Life Sciences brand
Copyright 2024 (C) Intellisphere, LLC
2 Commerce Drive
Cranbury, NJ 08512